Oral, ultra-long-acting medication on the horizon

Single administration drugs may soon deliver sustained dosages over weeks, months or potentially even years, research suggests Researchers from Brigham and Women's Hospital and the Massachusetts Institute of Technology in the US have designed a capsule-carried dosage form that can deliver up to 10 to 14 days of sustained, mosquitocidal ivermectin. The design involves star-shaped,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Forum: New brand premiums
Next Inhaler trial aims to reduce lung damage in smokers